Area of research
Oncology · Molecular Biology
Research interest
Research interests include Muscle Physiology and Disorders, Pancreatitis Pathology and Treatment, Pancreatic and Hepatic Oncology Research, and Osteoarthritis Treatment and Mechanisms.
Temporal dynamics and functional implications of MiRNAs in denervation-induced skeletal muscle atrophy
Celecoxib attenuates hindlimb unloading-induced muscle atrophy via suppressing inflammation, oxidative stress and ER stress by inhibiting STAT3
Inflammation: Roles in Skeletal Muscle Atrophy
Changes of Gene Expression Patterns of Muscle Pathophysiology-Related Transcription Factors During Denervated Muscle Atrophy
Identification of Regulatory Factors and Prognostic Markers in Amyotrophic Lateral Sclerosis
HDAC4 Knockdown Alleviates Denervation-Induced Muscle Atrophy by Inhibiting Myogenin-Dependent Atrogene Activation
Global alternative splicing landscape of skeletal muscle atrophy induced by hindlimb unloading
Inhibition of IL-6/JAK/STAT3 pathway rescues denervation-induced skeletal muscle atrophy
Isoquercitrin Delays Denervated Soleus Muscle Atrophy by Inhibiting Oxidative Stress and Inflammation
Aspirin alleviates denervation-induced muscle atrophy via regulating the Sirt1/PGC-1α axis and STAT3 signaling
Serum zinc level and tissue ZIP4 expression are related to the prognosis of patients with stages I–III colon cancer
PQQ ameliorates skeletal muscle atrophy, mitophagy and fiber type transition induced by denervation via inhibition of the inflammatory signaling pathways
miR-125b-5p targeting TRAF6 relieves skeletal muscle atrophy induced by fasting or denervation
Communication interventions for autism spectrum disorder in minimally verbal children
Strategies and potential therapeutic agents to counter skeletal muscle atrophy
First-onset mental disorders after cancer diagnosis and cancer-specific mortality: a nationwide cohort study
Immunotherapy (excluding checkpoint inhibitors) for stage I to III non-small cell lung cancer treated with surgery or radiotherapy with curative intent
Molecular-targeted first-line therapy for advanced gastric cancer
Prognostic role of microscopically positive margins for primary gastrointestinal stromal tumors: a systematic review and meta-analysis
Long-term proton pump inhibitor (PPI) use and the development of gastric pre-malignant lesions